Ownership and insider activity for Fonar Corp. (FONR): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
FONAR Corporation, together with its subsidiaries, engages in the designing, manufacturing, selling, and servicing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases, abnormalities, other medical conditions, and injuries in the United States. It operates in two segments: Medical Equipment, and Physician Management and Diagnostic Services.
Price
| Price | $19.09 |
| Market Cap | $118M |
| Exchange | NASDAQ |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2025-06-23 | Chan Claudette | |||
| 1987-10-15 | Chan Claudette | |||
| 2026-06-03 | Lehman Ronald G. | |||
| 2020-12-01 | Lehman Ronald G. | A-Award | 2,629 | |
| 2019-07-17 | Lehman Ronald G. | A-Award | 488 | |
| 2018-07-11 | Lehman Ronald G. | A-Award | 363 | |
| 2017-06-21 | Lehman Ronald G. | A-Award | 350 | |
| 2016-08-23 | Lehman Ronald G. | A-Award | 500 | |
| 2012-04-23 | Lehman Ronald G. | |||
| 2026-06-03 | Carrino Robert M. |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $8.5M | $10.1M | $19.7M | $13.9M | $36.8M | $44.5M | $48.7M | $51.3M | $56.3M | $56.3M |
| Short-term Investments | 0 | 0 | 0 | $15.1M | $31884 | $32177 | $32326 | $32799 | $136102 | $120494 |
| Receivables | $34.2M | $40.4M | $44.6M | $52.8M | $55.6M | $61.2M | $66.5M | $70.2M | $79.8M | $82.9M |
| Inventory | $2.1M | $1.6M | $1.4M | $1.8M | $1.6M | $1.7M | $2.4M | $2.6M | $2.7M | $2.8M |
| Total Current Assets | $45.6M | $53.4M | $67.1M | $85.1M | $95.9M | $108.6M | $118.7M | $125.7M | $140.3M | $144.7M |
| Property, Plant & Equipment | $14.5M | $16.5M | $16.5M | $17.0M | $54.1M | $53.1M | $57.4M | $55.9M | $57.7M | $54.0M |
| Goodwill | $3.3M | $3.9M | $4.0M | $4.0M | $4.0M | $4.3M | $4.3M | $4.3M | $4.3M | $4.3M |
| Intangible Assets | $7.7M | $6.6M | $5.6M | $4.8M | $4.1M | $4.0M | $3.7M | $3.4M | $2.9M | $3.0M |
| Total Assets | $84.9M | $98.8M | $118.3M | $133.6M | $180.3M | $189.5M | $199.3M | $200.6M | $214.2M | $216.9M |
| Accounts Payable | $1.3M | $1.4M | $1.3M | $1.9M | $2.0M | $1.9M | $1.6M | $1.6M | $1.9M | $1.3M |
| Short-term Debt | $2.4M | $180090 | $38332 | $40530 | 0 | $173206 | $40078 | $43767 | $47000 | 0 |
| Total Current Liabilities | $20.6M | $14.2M | $14.6M | $14.1M | $18.7M | $20.0M | $16.7M | $15.6M | $17.9M | $17.1M |
| Long-term Debt | $2.1M | $336761 | $306035 | $273112 | $865416 | $760254 | $155379 | $115075 | $66938 | 0 |
| Total Liabilities | $24.1M | $15.9M | $16.1M | $15.4M | $54.0M | $54.1M | $53.1M | $49.8M | $57.5M | $56.8M |
| Retained Earnings | -$120.6M | -$101.0M | -$79.8M | -$64.5M | -$56.2M | -$46.0M | -$33.6M | -$24.2M | -$13.6M | -$5.3M |
| Total Equity | $52.4M | $77.4M | $98.7M | $116.0M | $126.2M | $138.4M | $150.3M | $157.9M | $166.0M | $172.6M |
| Total Debt | $4.5M | $516851 | $344367 | $313642 | $35.7M | $34.7M | $38.2M | $37.0M | $41.7M | $38.9M |
| Net Debt | -$4.0M | -$9.6M | -$19.3M | -$28.7M | -$1.2M | -$9.8M | -$10.5M | -$14.3M | -$14.8M | -$17.5M |
| Working Capital | $24.9M | $39.2M | $52.5M | $71.0M | $77.2M | $88.5M | $101.9M | $110.0M | $122.5M | $127.5M |
Financial Health
| Debt / Equity | 0.22 |
| Current Ratio | 9.18 |
| Piotroski F-Score | 7 |
| Altman Z-Score | 2.33 |
Profitability
| Return on Equity | 3.81% |
| Return on Invested Capital | 3.59% |
| Return on Assets | 3.05% |
| Gross Margin | 40.26% |
| Operating Margin | 9.05% |
| Net Margin | 6.35% |
Related companies: APYX · ARTV · EDAP · HYPR · IFRX · LUNG · NSPR
Explore sector: Healthcare · Medical - Equipment & Services
More sections of FONR: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks